首页> 美国卫生研究院文献>Indian Journal of Microbiology >Molecular Physiological and Phenotypic Characterization of Paracoccus denitrificans ATCC 19367 Mutant Strain P-87 Producing Improved Coenzyme Q10
【2h】

Molecular Physiological and Phenotypic Characterization of Paracoccus denitrificans ATCC 19367 Mutant Strain P-87 Producing Improved Coenzyme Q10

机译:反硝化副球菌ATCC 19367突变株P-87产生改进的辅酶Q10的分子生理和表型表征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Coenzyme Q10 (CoQ10) is a blockbuster nutraceutical molecule which is often used as an oral supplement in the supportive therapy for cardiovascular diseases, cancer and neurodegenerative diseases. It is commercially produced by fermentation process, hence constructing the high yielding CoQ10 producing strains is a pre-requisite for cost effective production. Paracoccus denitrificans ATCC 19367, a biochemically versatile organism was selected to carry out the studies on CoQ10 yield improvement. The wild type strain was subjected to iterative rounds of mutagenesis using gamma rays and NTG, followed by selection on various inhibitors like CoQ10 structural analogues and antibiotics. The screening of mutants were carried out using cane molasses based optimized medium with feeding strategies at shake flask level. In the course of study, the mutant P-87 having marked resistance to gentamicin showed 1.25-fold improvements in specific CoQ10 content which was highest among all tested mutant strains. P-87 was phenotypically differentiated from the wild type strain on the basis of carbohydrate assimilation and FAME profile. Molecular differentiation technique based on AFLP profile showed intra specific polymorphism between wild type strain and P-87. This study demonstrated the beneficial outcome of induced mutations leading to gentamicin resistance for improvement of CoQ10 production in P. denitrificans mutant strain P-87. To investigate the cause of gentamicin resistance, rpIF gene from P-87 and wild type was sequenced. No mutations were detected on the rpIF partial sequence of P-87; hence gentamicin resistance in P-87 could not be conferred with rpIF gene. However, detecting the mutations responsible for gentamicin resistance in P-87 and correlating its role in CoQ10 overproduction is essential. Although only 1.25-fold improvement in specific CoQ10 content was achieved through mutant P-87, this mutant showed very interesting characteristic, differentiating it from its wild type parent strain P. denitrificans ATCC 19367, which are presented in this paper.Electronic supplementary materialThe online version of this article (doi:10.1007/s12088-014-0506-4) contains supplementary material, which is available to authorized users.
机译:辅酶Q10(CoQ10)是一种重磅炸弹的保健食品分子,通常在心血管疾病,癌症和神经退行性疾病的支持疗法中用作口服补品。它是通过发酵工艺商业生产的,因此构建高产CoQ10的菌株是经济高效生产的先决条件。选择了生物化学用途广泛的生物脱氮副球菌ATCC 19367进行CoQ10产量提高的研究。使用γ射线和NTG对野生型菌株进行轮回诱变,然后选择各种抑制剂如CoQ10结构类似物和抗生素。使用基于蔗糖蜜的优化培养基进行筛选,并在摇瓶水平上进料。在研究过程中,对庆大霉素具有明显抗性的突变体P-87在特定的CoQ10含量上提高了1.25倍,这在所有测试的突变菌株中最高。根据碳水化合物同化作用和FAME谱,P-87与野生型菌株在表型上有所区别。基于AFLP谱的分子分化技术显示了野生型菌株与P-87之间的内部特异性多态性。这项研究表明诱导突变导致庆大霉素抗性的有益结果,以改善反硝化假单胞菌突变株P-87的辅酶Q10产生。为了调查庆大霉素抗性的原因,对来自P-87和野生型的rpIF基因进行了测序。在P-87的rpIF部分序列上未检测到任何突变;因此,rpIF基因不能赋予P-87中的庆大霉素抗性。但是,检测P-87中庆大霉素抗性的突变并使其在辅酶Q10过量生产中的作用相关至关重要。尽管通过突变体P-87仅能将特定CoQ10含量提高1.25倍,但该突变体却表现出非常有趣的特性,与野生型亲本菌株反硝化杆菌ATCC 19367有所不同,后者已在本文中进行了介绍。本文的版本(doi:10.1007 / s12088-014-0506-4)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号